Biomarkers · Chemical
We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.
Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.
Laboratory assay overview
This test is used to aid in the diagnosis of acute viral hepatitis due to infection with HAV, HBV and/or HCV.
Labcorp test directory, test code 144000
Laboratory assay overview
This profile is intended to support evaluation following potential exposure to bloodborne pathogens (e.g., needle stick and other sharps injuries, mucous membrane exposure and skin exposure). This profile includes assays for the detection of HBV, HCV and HIV.
Labcorp test directory, test code 257524
Laboratory assay overview
This test is used for risk assessment and management of HBV infection status in patients prior to initiation of HCV treatment with direct-acting antiviral agents.
Labcorp test directory, test code 144547
Laboratory assay overview
This assay can be used in conjunction with other serological and clinical information to diagnose individuals with acute or chronic hepatitis B infection. This assay may also be used to screen for hepatitis B infection in pregnant women to identify neonates who are at risk of acquiring hepatitis B during the perinatal period.
Negative
Labcorp test directory, test code 006510
Laboratory assay overview
This profile is intended to aid in the diagnosis of active hepatitis B virus (HBV) infection (acute and chronic) with reflex of Hepatitis B surface antigen (HBsAg) positive samples to Hepatitis D virus (HDV) antibody testing to identify HDV coinfections. Testing for HDV RNA should be performed on HDV antibody-positive individuals to differentiate between active and resolved HDV infection.
Negative
Labcorp test directory, test code 006514
Laboratory assay overview
Surface antigen usually appears in the serum after an incubation period of 1 to 6 months following exposure to Hepatitis B virus and peaks shortly after onset of symptoms. It typically disappears within 1 to 3 months. Persistence of Hepatitis B Surface Antigen for greater than 6 months is a prognostic indicator of chronic Hepatitis B infection.
Non-Reactive
Quest Diagnostics test directory, test code 498
Laboratory assay overview
This panel is intended for use in the management of patients with chronic hepatitis B and to assess the efficacy of antiviral treatment. A positive HBsAg test will reflex to HBeAg, anti-HBe, HBV quantitative DNA, and ALT.
Labcorp test directory, test code 144149
Laboratory assay overview
This test is used for screening of pregnant women for hepatitis B virus (HBV) infection to identify neonates who are at risk of acquiring hepatitis B during the perinatal period. A positive HBsAg test will reflex to HBV quantitative DNA.
Labcorp test directory, test code 144523
Laboratory assay overview
This test is used for screening of pregnant women for hepatitis B virus (HBV) infection to identify neonates who are at risk of acquiring hepatitis B during the perinatal period.
Labcorp test directory, test code 144510
Laboratory assay overview
This is a triple test panel intended for screening and diagnosis of hepatitis B virus (HBV) infection. This panel can be used to identify different phases of HBV infection and to determine whether a patient has acute or chronic HBV infection, is immune to HBV as a result of prior infection or vaccination, or is susceptible to infection. This panel aligns with current CDC recommendations for HBV screening and testing.
Labcorp test directory, test code 144473
Laboratory assay overview
This is an HBV triple test panel intended for screening and diagnosis of hepatitis B virus (HBV) infection with reflex of Hepatitis B surface antigen (HBsAg) positive samples to Hepatitis D virus (HDV) antibody testing to identify HDV coinfections. This panel can be used to identify different phases of HBV infection and to determine whether a patient has acute or chronic HBV infection, is immune to HBV as a result of prior infection or vaccination or is susceptible to infection. Additionally, this panel identifies HBV-HDV coinfections.
Labcorp test directory, test code 144103
Laboratory assay overview
Biologic therapies can be used to treat many different autoimmune diseases, such as Inflammatory Bowel Disease, Rheumatoid Arthritis, and Psoriasis. Biologic therapies can be life-changing drugs but they can also suppress the immune system and put the patient at risk of infection. Because of this risk, it is recommended by the American Academy of Dermatology (AAD), American College of Gastroenterology (ACG) and the American College of Rheumatology (ACR) to screen patients for certain infectious diseases, including hepatitis B, hepatitis C and tuberculosis.1-3
Labcorp test directory, test code 144441
Laboratory assay overview
Initial screening profile intended for the first prenatal visit to evaluate health status in early pregnancy. This profile aligns with current clinical guidelines and recommendations (see references).
Labcorp test directory, test code 144053
Laboratory assay overview
This initial screening profile is intended for the first prenatal visit to evaluate health status in early pregnancy. This profile aligns with current clinical guidelines and recommendations and includes the HBV triple panel (see references).
Labcorp test directory, test code 144059
Laboratory assay overview
This initial screening profile is intended for the first prenatal visit to evaluate health status in early pregnancy. This profile aligns with current clinical guidelines and recommendations and includes the HBV triple panel, VZV IgG, and QuantiFERON-TB Gold Plus.
Labcorp test directory, test code 144099
Laboratory assay overview
This test is used for HBV screening and diagnosis in patients administered HIV PrEP. This is a triple test panel intended for screening and diagnosis of hepatitis B virus (HBV) infection. This panel can be used to identify different phases of HBV infection and to determine whether a patient has acute or chronic HBV as a result of prior infection or vaccination or is susceptible to infection. This panel aligns with current CDC recommendations for HBV screening and testing.
Labcorp test directory, test code 144696
Laboratory assay overview
This profile aligns with current guidelines for assessment of female patients prior to the initiation of injectable HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; serological assessment of HBV infection status; reflexive testing for the detection of HCV infection; and assessment of pregnancy status.
Labcorp test directory, test code 254988
Laboratory assay overview
This profile aligns with current guidelines for assessment of female patients prior to the initiation of oral HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; serological assessment of HBV infection status; reflexive testing for the detection of HCV infection; assessment of pregnancy status; and assessment of filtering capacity of the kidney (eGFR).
Labcorp test directory, test code 254855
Laboratory assay overview
This profile aligns with current guidelines for assessment of male patients prior to the initiation of injectable HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; serological assessment of HBV infection status; and reflexive testing for the detection of HCV infection.
Labcorp test directory, test code 254972
Laboratory assay overview
This profile aligns with current guidelines for assessment of male patients prior to the initiation of oral HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; serological assessment of HBV infection status; reflexive testing for the detection of HCV infection; and assessment of filtering capacity of the kidney (eGFR).
Labcorp test directory, test code 254842
Laboratory assay overview
This test is used to screen for and diagnose sexually transmitted infections and blood borne pathogens including syphilis, hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV. Testing aligns with current guidelines and recommendations.
Labcorp test directory, test code 144011
Laboratory assay overview
This test is used to screen for and diagnose sexually transmitted infections and blood borne pathogens including syphilis, hepatitis B virus (HBV), hepatitis C virus (HCV), HIV, Chlamydia trachomatis and Neisseria gonorrhoeae. Testing aligns with current guidelines and recommendations.
Labcorp test directory, test code 144082
Laboratory assay overview
This test is used to screen for and diagnose sexually transmitted infections and blood borne pathogens including syphilis, hepatitis B virus (HBV), hepatitis C virus (HCV), HIV, Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis. Testing aligns with current guidelines and recommendations.
Labcorp test directory, test code 144027
Laboratory assay overview
This test is used to aid in the diagnosis of viral hepatitis due to infection with HAV and/or HBV.
Labcorp test directory, test code 144552
Laboratory assay overview
This test is used to aid in the diagnosis of viral hepatitis due to infection with HAV, HBV and/or HCV.
Labcorp test directory, test code 144445
Laboratory assay overview
This test is used to aid in the diagnosis of viral hepatitis due to infection with HBV and/or HCV.
Labcorp test directory, test code 144025
We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.
Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.